Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

China · Delayed Price · Currency is CNY

17.22

-0.39 (-2.21%)

Sep 2, 2026, 3:00 PM CST

-53.86% (1Y)

Market Cap	4.39B -52.8%
Revenue (ttm)	3.00B +13.4%
Net Income	118.38M -23.5%
EPS	0.47 -26.1%
Shares Out	249.40M
PE Ratio	37.34
Forward PE	14.92
Dividend	0.16 (0.92%)
Ex-Dividend Date	May 12, 2026

Volume	4,784,934
Open	17.54
Previous Close	17.61
Day's Range	17.13 - 17.71
52-Week Range	14.52 - 43.60
Beta	0.15
Analysts	Strong Buy
Price Target	36.37 (+111.21%)
Earnings Date	Aug 25, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2005

Employees 2,252

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688639

Full Company Profile

Financial Performance

In 2025, SHA:688639's revenue was 2.86 billion, an increase of 31.40% compared to the previous year's 2.18 billion. Earnings were 132.41 million, a decrease of -30.13%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 688639 stock is "Strong Buy." The 12-month stock price target is ¥36.37, which is an increase of 111.21% from the latest price.

Price Target

¥36.37

(111.21% upside)

Analyst Consensus: Strong Buy

Stock Forecasts